Position in IXHL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$73,509
New position
Shares Held
24,503
first reported quarter
Ownership
0.205%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#8
of 20 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AdvisorShares Investments LLC holds $8,678,668 across 12 Drug Manufacturers - Specialty & Generic names. IXHL ranks #12 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRON |
Cronos Group Inc.
|
532,394 | $1,336,308 | |
| 2 | OGI |
Organigram Global Inc.
|
947,440 | $1,269,569 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
36,431 | $1,097,301 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
7,170 | $944,575 | |
| 5 | ALKS |
Alkermes plc.
|
26,369 | $932,407 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
17,453 | $902,145 | |
| 7 | ACB |
Aurora Cannabis Inc
|
171,110 | $559,529 | |
| 8 | ROMJF |
Rubicon Organics Inc.
|
1,498,936 | $535,120 |
All Filings in IXHL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,509 | 24,503 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||